Deal Announcements

FAAH Pharma Nets Venture Capital Investment

Thursday, August 14, 2014 5:45:00 AM PDT | VentureDeal

Montréal, Canada  --  Pharmaceutical technology company FAAH Pharma has secured an undisclosed amount of venture capital investment.

FAAH is developing a compound to treat postherpetic neuralgia.

TVM Capital made the investment.

Specific proceeds purposes were not disclosed, however the company appears to be ready to begin Phase 2a trials of its lead compound.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1